117 related articles for article (PubMed ID: 7041380)
21. Clinical significance of circulating immune complexes in patients with metastatic breast cancer.
Krieger G; Kehl A; Wander HE; Salo AM; Rauschecker HF; Nagel GA
Int J Cancer; 1983 Feb; 31(2):207-11. PubMed ID: 6826249
[TBL] [Abstract][Full Text] [Related]
22. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
23. [Current situation and problems in the estimation of circulating immune complexes].
Yoshida H
Rinsho Byori; 1992 Jan; 40(1):28-33. PubMed ID: 1545522
[TBL] [Abstract][Full Text] [Related]
24. Characterization of immune complexes detected by the 125I-C1q binding assay in breast cancer.
Krieger G; Kneba M; Bolz I; Nagel GA
Clin Immunol Immunopathol; 1988 Jan; 46(1):14-23. PubMed ID: 3257175
[TBL] [Abstract][Full Text] [Related]
25. Circulating immune complexes and C1 activation in patients with rapidly progressive glomerulonephritis, before and after treatment with immunosuppression and plasma exchange.
Sjöholm AG; Brun C; Larsen S; Thysell H
Int Arch Allergy Appl Immunol; 1983; 72(1):9-15. PubMed ID: 6874103
[TBL] [Abstract][Full Text] [Related]
26. Detection of IgA-class circulating immune complexes (CIC) in sera from patients with IgA nephropathy using a solid-phase anti-C3 Facb enzyme immunoassay (EIA).
Yagame M; Tomino Y; Miura M; Tanigaki T; Suga T; Nomoto Y; Sakai H
Clin Exp Immunol; 1987 Feb; 67(2):270-6. PubMed ID: 3301093
[TBL] [Abstract][Full Text] [Related]
27. [A method of isolating C1q from human serum and its use in the solid-phase immunoenzyme determination of immune complexes].
Belozerov AP
Lab Delo; 1989; (3):24-6. PubMed ID: 2469833
[TBL] [Abstract][Full Text] [Related]
28. A solid phase C1q enzyme assay for circulating immune complexes adapted for routine clinical laboratory testing.
James K; Vahey A; Robinson M; Marder R
Am J Clin Pathol; 1983 Oct; 80(4):445-52. PubMed ID: 6353904
[TBL] [Abstract][Full Text] [Related]
29. Detection of immune complexes using a solid-phase C1q polystyrene ball assay.
Pohl DA; Tsai CC; Roodman ST
J Immunol Methods; 1981; 40(3):313-30. PubMed ID: 7252164
[TBL] [Abstract][Full Text] [Related]
30. Solid phase C1q microassay for the rapid detection of circulating immune complexes.
Orozco A; Contreras CE; Sánchez P; Meilijson O; Bianco NE
J Immunol Methods; 1983 Apr; 59(2):237-43. PubMed ID: 6341470
[TBL] [Abstract][Full Text] [Related]
31. Circulating immune complexes in systemic lupus erythematosus: a reappraisal of the solid phase C1q radioimmunoassay.
Woodroffe AJ; Nozza JM; Muller KD; McIntosh SL; Hale GM; Clarkson AR
J Clin Lab Immunol; 1988 May; 26(1):5-7. PubMed ID: 3263507
[TBL] [Abstract][Full Text] [Related]
32. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
Antes U; Heinz HP; Loos M
Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
[TBL] [Abstract][Full Text] [Related]
33. A new C1q solid-phase assay for the detection of IgM immune complexes: application to the follow-up of kidney graft recipients with recurrent cytomegalovirus infection.
Basson J; Tardy JC; Aymard M
J Clin Lab Immunol; 1990 Jan; 31(1):43-9. PubMed ID: 1966984
[TBL] [Abstract][Full Text] [Related]
34. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
Wu CC; Bey RF; Loken KI
Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
[TBL] [Abstract][Full Text] [Related]
35. Detection of circulating immune complexes by a Clq/protein A-ELISA during the preneoplastic stages of feline leukemia virus infection.
Tuomari DL; Olsen RG; Singh VK; Kraut EH
Vet Immunol Immunopathol; 1984 Oct; 7(3-4):227-38. PubMed ID: 6095518
[TBL] [Abstract][Full Text] [Related]
36. Circulating immune complexes detected by C1q solid phase assay in leprosy.
Nuti M; D'Amelio R; Seminara R; Milano CF; Palmisano L; Aiuti F
Int J Lepr Other Mycobact Dis; 1981 Mar; 49(1):27-30. PubMed ID: 6972924
[TBL] [Abstract][Full Text] [Related]
37. C1q deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum.
Sobel AT; Bokisch VA; Müller-Eberhard HJ
J Exp Med; 1975 Jul; 142(1):139-50. PubMed ID: 1097571
[TBL] [Abstract][Full Text] [Related]
38. Circulating immune complexes in breast cancer patients.
Croce MV; Pasqualini RS; Segal-Eiras A
Medicina (B Aires); 1987; 47(4):371-6. PubMed ID: 3502571
[No Abstract] [Full Text] [Related]
39. [The development of a C1q-solid-phase immunoenzyme method for determining circulating immune complexes].
Nedugova GI
Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):56-9. PubMed ID: 1716037
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
